ZNTL · Zentalis Pharmaceuticals, Inc.
$3.56
-0.59 (-14.22%)
At close · Aug 14
Market Cap
$255.15M
Shares
71.67M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ZNTL
49 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,694,426 | $3,964,957 | 0.00% | Long | 2026-03-31 | |
| PRIMECAP Odyssey Aggressive Growth Fund | — | 676,400 | $2,712,364 | 0.04% | Long | 2026-04-30 | |
| Franklin Biotechnology Discovery Fund | — | 440,039 | $1,764,556 | 0.17% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 543,757 | $1,272,391 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 263,826 | $1,055,304 | 0.00% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 150,598 | $602,392 | 0.00% | Long | 2026-05-31 | |
| Fidelity Enhanced Small Cap ETF | — | 237,653 | $556,108 | 0.01% | Long | 2026-03-31 | |
| Invesco RAFI US 1500 Small-Mid ETF | — | 125,701 | $504,061 | 0.02% | Long | 2026-04-30 | |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND | — | 209,330 | $489,832 | 0.02% | Long | 2026-03-31 | |
| Dimensional U.S. Small Cap ETF | — | 112,118 | $449,593 | 0.00% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 99,589 | $398,356 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | — | 159,946 | $374,274 | 0.03% | Long | 2026-03-31 | |
| Federated Hermes MDT Small Cap Core ETF | — | 79,362 | $317,448 | 0.11% | Long | 2026-05-31 | |
| Avantis U.S. Small Cap Equity ETF | — | 78,150 | $312,600 | 0.01% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 77,330 | $309,320 | 0.00% | Long | 2026-05-31 | |
| Schwab Total Stock Market Index Fund | — | 50,000 | $200,500 | 0.00% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 46,138 | $184,552 | 0.00% | Long | 2026-05-31 | |
| LVIP State Street Small-Cap Index Fund | — | 37,500 | $181,875 | 0.01% | Long | 2026-06-30 | |
| Ultra-Small Company Market Fund | — | 77,300 | $180,882 | 0.15% | Long | 2026-03-31 | |
| U.S. MICRO CAP PORTFOLIO | — | 32,904 | $131,945 | 0.00% | Long | 2026-04-30 | |
| VIP Disciplined Small Cap Portfolio | — | 42,799 | $100,150 | 0.02% | Long | 2026-03-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 24,556 | $98,470 | 0.00% | Long | 2026-04-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 38,041 | $89,016 | 0.00% | Long | 2026-03-31 | |
| Range Cancer Therapeutics ETF | ABUF | 42,768 | $88,530 | 0.99% | Long | 2025-02-28 | |
| VANGUARD BALANCED INDEX FUND | — | 34,483 | $80,690 | 0.00% | Long | 2026-03-31 | |
| Small-Cap Index Portfolio | — | 14,364 | $69,665 | 0.01% | Long | 2026-06-30 | |
| Defiance Nasdaq Junior Biotechnology ETF | ABUF | 1,030 | $68,639 | 0.95% | Long | 2021-09-30 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 24,619 | $57,608 | 0.00% | Long | 2026-03-31 | |
| Dimensional US Core Equity Market ETF | — | 10,252 | $41,111 | 0.00% | Long | 2026-04-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 15,600 | $36,504 | 0.00% | Long | 2026-03-31 | |
| U.S. CORE EQUITY 1 PORTFOLIO | — | 8,463 | $33,937 | 0.00% | Long | 2026-04-30 | |
| iShares Evolved U.S. Innovative Healthcare ETF | AGRH | 968 | $28,266 | 0.08% | Long | 2022-07-31 | |
| 1290 VT Micro Cap Portfolio | — | 11,776 | $27,556 | 0.02% | Long | 2026-03-31 | |
| U.S. CORE EQUITY 2 PORTFOLIO | — | 5,900 | $23,659 | 0.00% | Long | 2026-04-30 | |
| JNL/DFA U.S. Small Cap Fund | — | 10,060 | $23,540 | 0.00% | Long | 2026-03-31 | |
| U.S. VECTOR EQUITY PORTFOLIO | — | 5,790 | $23,218 | 0.00% | Long | 2026-04-30 | |
| PD Small-Cap Value Index Portfolio | — | 3,802 | $18,440 | 0.01% | Long | 2026-06-30 | |
| Diversified Equity Master Portfolio | — | 7,312 | $17,110 | 0.00% | Long | 2026-03-31 | |
| LVIP Dimensional U.S. Core Equity 1 Fund | — | 3,380 | $16,393 | 0.00% | Long | 2026-06-30 | |
| LVIP Dimensional U.S. Core Equity 2 Fund | — | 2,690 | $13,047 | 0.00% | Long | 2026-06-30 | |
| Principal Healthcare Innovators ETF | BCHP | 2,719 | $11,121 | 0.07% | Long | 2024-06-30 | |
| Small-Cap Equity Portfolio | — | 2,130 | $10,331 | 0.00% | Long | 2026-06-30 | |
| JNL/DFA U.S. Core Equity Fund | — | 3,338 | $7,811 | 0.00% | Long | 2026-03-31 | |
| Small-Mid Cap Equity Fund | MSLC | 2,160 | $7,798 | 0.00% | Long | 2024-11-30 | |
| AZL DFA U.S. Core Equity Fund | — | 2,020 | $4,727 | 0.00% | Long | 2026-03-31 | |
| Guggenheim Active Allocation Fund | GUG | 428 | $1,712 | 0.00% | Long | 2026-05-29 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 361 | $1,448 | 0.00% | Long | 2026-04-30 | |
| V-Shares US Leadership Diversity ETF | KAMO | 2 | $33 | 0.00% | Long | 2023-10-31 | |
| Convergence Long/Short Equity Fund | APCB | 344 | $28,225 | -0.10% | Short | 2021-11-30 |
Showing 1–49 of 49 positions
Key facts
CIK
1725160
CUSIP
98943L107
13F (30d)
114 filings
111 filers
Visit website
Investor relations